Mounjaro

DRUG2 trials

Sponsors

University Health Network, Toronto, Nicholas Skertich

Conditions

Atypical HyperplasiaEndometrial CancerObesity and Obesity-related Medical Conditions

Early Phase 1

Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss

RecruitingNCT06734273

Nicholas SkertichObesity and Obesity-related Medical Conditions

Start: 2025-03-10End: 2028-03-31Target: 42Updated: 2025-03-14

Phase 2

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Not yet recruitingNCT06073184

University Health Network, TorontoAtypical Hyperplasia, Endometrial Cancer

Start: 2025-08-31End: 2032-02-29Target: 71Updated: 2025-06-10